|
|
|
Volumn 9, Issue 4, 1996, Pages 292-295
|
|
Treatment of heparin-induced thrombocytopenia and thrombosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANCROD;
ANTITHROMBOCYTIC AGENT;
ARGATROBAN;
DANAPAROID;
DEXTRAN;
DEXTRAN 40;
GLYCOSAMINOGLYCAN;
HEPARIN;
HEPARIN DERIVATIVE;
LOW MOLECULAR WEIGHT HEPARIN;
THROMBOCYTE ANTIBODY;
THROMBOCYTE FACTOR 4;
WARFARIN;
CLINICAL TRIAL;
CROSS REACTION;
DEEP VEIN THROMBOSIS;
DRUG FORMULATION;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
HEPARINIZATION;
HIP SURGERY;
HUMAN;
MAJOR CLINICAL STUDY;
PHASE 3 CLINICAL TRIAL;
PLASMAPHERESIS;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTE ACTIVATION;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOSIS;
ANCROD;
ANTICOAGULANTS;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
PLATELET ACTIVATION;
THROMBOCYTOPENIA;
|
|
EID: 0029822495
PISSN: 08957967
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
